| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.714 | 27.724 | 25.194 | 17.611 | 14.400 | 15.046 | 11.946 | 14.936 | 17.200 | 18.604 |
| Total Income - EUR | 12.714 | 27.734 | 26.193 | 18.330 | 14.400 | 15.091 | 11.946 | 15.019 | 17.200 | 18.604 |
| Total Expenses - EUR | 7.950 | 28.181 | 29.915 | 12.347 | 3.660 | 3.791 | 4.300 | 5.458 | 5.181 | 5.271 |
| Gross Profit/Loss - EUR | 4.764 | -447 | -3.723 | 5.983 | 10.740 | 11.300 | 7.646 | 9.561 | 12.019 | 13.333 |
| Net Profit/Loss - EUR | 4.477 | -721 | -3.975 | 5.583 | 10.308 | 10.861 | 7.331 | 9.122 | 10.094 | 10.965 |
| Employees | 2 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Transmed Best S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 66.005 | 64.387 | 61.375 | 55.682 | 52.419 | 49.343 | 46.240 | 45.864 | 43.354 | 40.755 |
| Current Assets | 16.070 | 8.968 | 8.691 | 6.113 | 3.876 | 7.962 | 17.895 | 4.866 | 10.781 | 6.223 |
| Inventories | 3.185 | 4.576 | 3.987 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 12.818 | 2.476 | 4.003 | 1.555 | 1.674 | 1.609 | 1.702 | 2.566 | 2.839 | 2.916 |
| Cash | 67 | 1.916 | 701 | 4.558 | 2.202 | 6.353 | 16.194 | 2.300 | 7.942 | 3.308 |
| Shareholders Funds | 77.458 | 62.586 | 53.174 | 57.924 | 48.776 | 48.376 | 54.635 | 9.171 | 19.237 | 30.094 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.618 | 10.768 | 16.891 | 3.872 | 7.519 | 8.928 | 9.501 | 41.559 | 34.899 | 16.884 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Transmed Best S.r.l.